Home > Drugs A – Z > Nylidrin (Oral route)
  • We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Nylidrin (Oral route)

What works?

Learn more about the effects of these drugs. The most reliable research is summed up for you in our featured article.

Nylidrin belongs to the group of medicines called vasodilators. Vasodilators increase the size of blood vessels. Nylidrin is used to treat problems due to poor blood circulation. Nylidrin was available only with your doctor's prescription. Nylidrin is no longer available in the United States… Read more
Drug classes About this
Peripheral Vasodilator

What works? Research summarized

Evidence reviews

Pentoxifylline for intermittent claudication

Atherosclerosis or hardening of the arteries results in narrowing and blockages in the arteries and can reduce the blood supply to the legs causing peripheral arterial occlusive disease. Intermittent claudication (IC) is a cramp‐like pain felt in the leg muscles that is brought on by walking and relieved by standing still or resting. Pentoxifylline is a drug that is used to relieve IC and to improve people’s walking capacity. It decreases blood viscosity and improves red blood cell flexibility, increasing microcirculatory blood flow and the amount of oxygen in the tissues. This review looked at all available evidence from randomised controlled trials on the efficiency of pentoxifylline in the treatment of IC.

Summaries for consumers

Pentoxifylline for intermittent claudication

Atherosclerosis or hardening of the arteries results in narrowing and blockages in the arteries and can reduce the blood supply to the legs causing peripheral arterial occlusive disease. Intermittent claudication (IC) is a cramp‐like pain felt in the leg muscles that is brought on by walking and relieved by standing still or resting. Pentoxifylline is a drug that is used to relieve IC and to improve people’s walking capacity. It decreases blood viscosity and improves red blood cell flexibility, increasing microcirculatory blood flow and the amount of oxygen in the tissues. This review looked at all available evidence from randomised controlled trials on the efficiency of pentoxifylline in the treatment of IC.

PubMed Health Blog...

read all...